Physician profile
Nicole Fleming
NPI 1881890796
$19,569.93
in general payments reported to CMS, 2019-2025
17 companies · $18.16 in 2025
The $18.16 reported for 2025 was less than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $334 · 2021: $2,188 · 2022: $35.91 · 2023: $214 · 2024: $3,133 · 2025: $18.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,800 · Food and Beverage: $388 · Education: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,800.00 |
| Food and Beverage | $387.84 |
| Education | $176.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tesaro, INC. | $7,567.16 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $5,724.67 | 2019-2020 | |
| Glaxosmithkline, LLC. | $5,070.58 | 2020-2024 | Zejula |
| Genentech USA, INC. | $261.31 | 2019 | |
| Clovis Oncology, INC. | $182.22 | 2019-2020 | |
| Eisai INC. | $176.50 | 2024 | |
| Celgene Corporation | $125.00 | 2020 | |
| Gilead Sciences, INC. | $80.73 | 2023-2024 | |
| Nestle Healthcare Nutrition INC. | $71.52 | 2023 | |
| Immunogen, INC. | $63.33 | 2023 | Elahere |
| Hologic Sales and Service, LLC | $50.60 | 2024 | Thinprep 2000 Processor, Aptima |
| Ferring Pharmaceuticals INC. | $45.29 | 2023-2024 | Rebyota |
| Mayne Pharma Commercial LLC | $42.22 | 2024 | |
| Ethicon US, LLC | $39.09 | 2022-2023 | Evarrest, Vistaseal, Surgiflo Hemostatic Matrix |
| Agile Therapeutics, INC. | $26.00 | 2021-2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $25.55 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $18.16 | 2025 | Abilify Asimtufii |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Fleming listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.